RotationRx · Drugs · Scores · Protocols · Diagnoses · Specialties

← Drug Reference

Rho(D) immune globulin

Prevention of Rh immunization in Rh-negative women, Prevention of Rh immunization after incompatible transfusion

Indications

  • Prevention of Rh immunization in Rh-negative women
  • Prevention of Rh immunization after incompatible transfusion

Adult dosing

  • antepartum 26 28 weeks: dose: 300; unit: mcg; route: IM; interval: single dose at 26-28 weeks; repeat postpartum within 72 h if newborn Rh-positive; fixed: true; labelExcerpt: RhoGAM (300 µg) (1500 IU) Postpartum (if the newborn is Rh-positive) Administer within 72 hour

Pediatric dosing

  • Consult pharmacy/current label

Renal adjustment

  • Consult pharmacy/current label

Hepatic adjustment

  • Consult pharmacy/current label

Contraindications

  • Rh-positive individuals
  • History of anaphylactic reaction to human immune globulin

Clinical pearls

  • Administer by intramuscular injection only.
  • Observe patients for at least 20 minutes following administration.
  • Monitor patients treated for incompatible transfusion for signs of hemolytic reaction.
  • May cause positive serological testing results due to passively transferred antibodies.

Source and review

  • DailyMed label (human rho(d) immune globulin, RhoGAM Ultra-Filtered PLUS), Set ID d87e4d0b-2442-4135-b3f9-5c4f74845b87, effective 2025-07-24. Last reviewed: 2026-11-11